101
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD

, , , , , , & show all
Pages 3983-3995 | Published online: 13 Dec 2018

References

  • AdeloyeDChuaSLeeCGlobal and regional estimates of COPD prevalence: systematic review and meta-analysisJ Glob Health20155202041526755942
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)From the global strategy for the diagnosis, management and prevention of COPD2017 Available from: http://goldcopd.orgAccessed May 1, 2017
  • RocheNSmallMBroomfieldSHigginsVPollardRReal world COPD: association of morning symptoms with clinical and patient reported outcomesCOPD201310667968624127914
  • MiravitllesMRiberaAUnderstanding the impact of symptoms on the burden of COPDRespir Res20171816728431503
  • BridevauxPOGerbaseMWProbst-HenschNMSchindlerCGaspozJMRochatTLong-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPDThorax200863976877418505800
  • RennardSIDrummondMBEarly chronic obstructive pulmonary disease: definition, assessment, and preventionLancet201538599791778178825943942
  • MiravitllesMWorthHSoler CataluñaJJObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS studyRespir Res20141512225331383
  • TsiligianniIKocksJTzanakisNSiafakasNvan der MolenTFactors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlationsPrim Care Respir J201120325726821472192
  • MonteagudoMRodríguez-BlancoTLlagosteraMFactors associated with changes in quality of life of COPD patients: a prospective study in primary careRespir Med2013107101589159723786889
  • PriceDSmallMMilliganGHigginsVGilEGEstruchJImpact of night-time symptoms in COPD: a real-world study in five European countriesInt J Chron Obstruct Pulmon Dis2013859560324348032
  • ZafariZSinDDPostmaDSIndividualized prediction of lung-function decline in chronic obstructive pulmonary diseaseCMAJ2016188141004101127486205
  • HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
  • SadatsafaviMSinDDZafariZThe association between rate and severity of exacerbations in chronic obstructive pulmonary disease: an application of a joint frailty-logistic modelAm J Epidemiol2016184968168927737842
  • JamesonJLLongoDLPrecision medicine – personalized, problematic, and promisingN Engl J Med2015372232229223426014593
  • Lopez-CamposJLCaleroCQuintana-GallegoESymptom variability in COPD: a narrative reviewInt J Chron Obstruct Pulmon Dis2013823123823687444
  • MiravitllesMMenezesALópez VarelaMVPrevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: the LASSYC observational studyRespir Med2018134626929413510
  • PartridgeMRKarlssonNSmallIRPatient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet surveyCurr Med Res Opin20092582043204819569976
  • Espinosa de Los MonterosMJPeñaCSoto HurtadoEJJareñoJMiravitllesMVariability of respiratory symptoms in severe COPDArch Bronconeumol20124813721944843
  • DonaldsonGCGoldringJJWedzichaJAInfluence of season on exacerbation characteristics in patients with COPDChest201214119410021799024
  • BourbeauJTanWCBenedettiACanadian Cohort Obstructive Lung Disease (CanCOLD): fulfilling the need for longitudinal observational studies in COPDCOPD201411212513222433011
  • HankinsonJLOdencrantzJRFedanKBSpirometric reference values from a sample of the general U.S. populationAm J Respir Crit Care Med199915911791879872837
  • FletcherCMElmesPCFairbairnASWoodCHThe significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working populationBr Med J19592514725726613823475
  • AndradeSEKahlerKHFrechFChanKAMethods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiol Drug Saf200615856557416514590
  • Ten HaveTRLocalioAREmpirical Bayes estimation of random effects parameters in mixed effects logistic regression modelsBiometrics19995541022102911315043
  • KesslerRPartridgeMRMiravitllesMSymptom variability in patients with severe COPD: a pan-European cross-sectional studyEur Respir J201137226427221115606
  • SumnerHWoodcockAKolsumUPredictors of objective cough frequency in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187994394923471467
  • FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
  • AgustiACalverleyPMCelliBCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
  • BarskyAJPeeknaHMBorusJFSomatic symptom reporting in women and menJ Gen Intern Med200116426627511318929
  • JohnsonKMBryanSGhanbarianSSinDDSadatsafaviMCharacterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysisRespir Res20181912629415723